- Home
- TWIN vs FENC Comparison
TWIN vs FENC Comparison
Compare TWIN & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TWIN | FENC |
|---|---|---|
| Founded | 1918 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 320.9M | 366.8M |
| IPO Year | 1994 | 2010 |
Fundamental Metrics
Financial Performance| Metric | TWIN | FENC |
|---|---|---|
| Price | $23.82 | $10.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $17.67 |
| AVG Volume (30 Days) | 63.3K | ★ 109.3K |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | ★ 0.84% | N/A |
| EPS Growth | ★ 1428.57 | N/A |
| EPS | ★ 1.86 | 0.06 |
| Revenue | ★ $381,270,000.00 | $44,642,000.00 |
| Revenue This Year | $7.56 | $62.55 |
| Revenue Next Year | $8.00 | $42.10 |
| P/E Ratio | ★ $12.78 | $172.00 |
| Revenue Growth | ★ 11.90 | N/A |
| 52 Week Low | $14.22 | $5.65 |
| 52 Week High | $29.24 | $13.25 |
Technical Indicators
Market Signals| Indicator | TWIN | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 39.58 | 44.81 |
| Support Level | $23.56 | $9.87 |
| Resistance Level | $24.52 | $10.66 |
| Average True Range (ATR) | 1.16 | 0.50 |
| MACD | -0.36 | 0.02 |
| Stochastic Oscillator | 3.91 | 38.38 |
Price Performance
Historical ComparisonAbout TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.